deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT04176419

Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery

Investigating the Effect of a Perioperative Analgesia Protocol on Postoperative Opioid Usage and Pain Control in Patients Undergoing Major Head and Neck Cancer Surgery Requiring Microvascular Free Flap Reconstruction

Sponsor: Case Comprehensive Cancer Center

Updated 14 times since 2019 Last updated: Nov 8, 2024 Started: Jan 17, 2020 Primary completion: Jun 23, 2021 Completion: Jun 23, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Workforce shortage

Listed as NCT04176419, this PHASE3 trial focuses on Opioid Consumption and Postoperative Pain Control and remains terminated or withdrawn. Sponsored by Case Comprehensive Cancer Center, it has been updated 14 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Jun 2021 · 4 months · monthly snapshot~Jun 2021 – ~Feb 2022 · 8 months · monthly snapshot~Feb 2022 – ~Jun 2022 · 4 months · monthly snapshot~Jun 2022 – ~Jan 2023 · 7 months · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~Nov 2023 · 9 months · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – present · 21 months · monthly snapshot

Change History

14 versions recorded
  1. Dec 2024 — Present [monthly]

    Terminated PHASE3

    Status: Active Not RecruitingTerminated

  2. Sep 2024 — Dec 2024 [monthly]

    Active Not Recruiting PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE3

  4. Nov 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE3

  5. Feb 2023 — Nov 2023 [monthly]

    Active Not Recruiting PHASE3

Show 9 earlier versions
  1. Jan 2023 — Feb 2023 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  2. Jun 2022 — Jan 2023 [monthly]

    Recruiting PHASE3

  3. Feb 2022 — Jun 2022 [monthly]

    Recruiting PHASE3

  4. Jun 2021 — Feb 2022 [monthly]

    Recruiting PHASE3

  5. Feb 2021 — Jun 2021 [monthly]

    Recruiting PHASE3

  6. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE3

  7. Feb 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

  8. Jan 2020 — Feb 2020 [monthly]

    Not Yet Recruiting PHASE3

  9. Dec 2019 — Jan 2020 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Case Comprehensive Cancer Center
Data source: Case Comprehensive Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations